US FDA accepts Cytovation's IND application for Phase II combination studies of CyPep-1, a first-in-class targeted tumor membrane immunotherapy PR Newswire
Philip Morris Holland Holdings B.V., an Affiliate of Philip Morris International Inc., Announces a Recommended Cash Offer of SEK 106 Per Share to the Shareholders of Swedish Match AB Business Wire